"How does Canada handle regulatory exlcusivity?

​

...Like in the United States, where the Food and Drug Administration, or FDA, is responsible for approving drug products both brand and generic, in Canada, that agency is called Health Canada. Like the USFDA, Health Canada grants certain regulatory exclusivity for branded drug products, but there are some differences. For example, in Canada, there's no orphan drug exclusivity, or new product exclusivity for branded drug products. Health Canada only grants regulatory exclusivity for the first approval of a novel active pharmaceutical ingredient, whereas in the United States, new chemical entity exclusivity means that generic manufacturers cannot file an application to market a generic drug product until four years after the brand gets approval, and generics cannot be approved themselves until at least seven and a half years after brand approval."